A screen for modifiers of Cyclin E function in Drosophila melanogaster identifies Cdk2 mutations, revealing the insignificance of putative phosphorylation sites in Cdk2

被引:0
|
作者
Lane, ME [1 ]
Elend, M [1 ]
Heidmann, D [1 ]
Herr, A [1 ]
Marzodko, S [1 ]
Herzig, A [1 ]
Lehner, CF [1 ]
机构
[1] Univ Bayreuth, Dept Genet, D-95440 Bayreuth, Germany
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In higher eukaryotes, cyclin E is thought to control the progression from G1 into S phase of the cell cycle by associating as a regulatory subunit with cdk2. To identify genes interacting with cyclin E, we have screened in Drosophila melanogaster for mutations that act as dominant modifiers of ail eye phenotype caused by a Sevenless-CycE transgene that directs ectopic Cyclin E expression in postmitotic cells of eye imaginal disc and causes a rough eye phenotype in adult flies. The majority of the EMS-induced mutations that we have identified fall into four complementation groups corresponding to the genes split ends, dacapo, dE2F1, and Cdk2(Cdc2c). The Cdk2 mutations in combination with mutant Cdk2 transgenes have allowed us to address the regulatory significance of potential phosphorylation sites in Cdk2 (Thr 18 and Tyr 19). The corresponding sites in the closely related Cdk1 (Thr 14 and Tyr 15) are of crucial importance for regulation of the G2/M transition by myt1 and wee1 kinases and cdc25 phosphatases. In contrast, our results demonstrate that the equivalent sites in Cdk2 play no essential role.
引用
收藏
页码:233 / 244
页数:12
相关论文
共 50 条
  • [21] Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2
    Morisaki, H
    Fujimoto, A
    Ando, A
    Nagata, Y
    Ikeda, K
    Nakanishi, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 240 (02) : 386 - 390
  • [22] Mechanism of Cdk2/cyclin E inhibition by p27 and p27 phosphorylation
    Xu, X
    Nakano, T
    Wick, S
    Dubay, M
    Brizuela, L
    BIOCHEMISTRY, 1999, 38 (27) : 8713 - 8722
  • [23] PKCη associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes
    Kashiwagi, M
    Ohba, M
    Watanabe, H
    Ishino, K
    Kasahara, K
    Sanai, Y
    Taya, Y
    Kuroki, T
    ONCOGENE, 2000, 19 (54) : 6334 - 6341
  • [24] PKCη associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes
    Mariko Kashiwagi
    Motoi Ohba
    Hiroyuki Watanabe
    Keiko Ishino
    Kohji Kasahara
    Yutaka Sanai
    Yoichi Taya
    Toshio Kuroki
    Oncogene, 2000, 19 : 6334 - 6341
  • [25] CDK2 heterobifunctional degraders co-degrade CDK2 and Cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers
    Kwiatkowski, N.
    Liang, T.
    Sha, Z.
    Collier, P.
    Yang, A.
    Sathappa, M.
    Paul, A.
    Su, L.
    Zheng, X.
    Li, K.
    Mehovic, R.
    Breitkopf, S.
    Howarth, C.
    Yuan, K.
    Sharma, K.
    Jo, H.
    Growney, J.
    Weiss, M.
    Williams, J.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S44 - S44
  • [26] DIFFERENTIAL REGULATION OF E2F TRANSACTIVATION BY CYCLIN CDK2 COMPLEXES
    DYNLACHT, BD
    FLORES, O
    LEES, JA
    HARLOW, E
    GENES & DEVELOPMENT, 1994, 8 (15) : 1772 - 1786
  • [27] CDK2 and cyclin E knockout mice: lessons from breast cancer
    Lents, NH
    Baldassare, JJ
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (01): : 1 - 3
  • [28] A role for cyclin E/Cdk2 in the timing of the midblastula transition in Xenopus embryos
    Hartley, RS
    Sible, JC
    Lewellyn, AL
    Maller, JL
    DEVELOPMENTAL BIOLOGY, 1997, 188 (02) : 312 - 321
  • [29] CONCURRENT AMPLIFICATION OF CYCLIN-E AND CDK2 GENES IN COLORECTAL CARCINOMAS
    KITAHARA, K
    YASUI, W
    KUNIYASU, H
    YOKOZAKI, H
    AKAMA, Y
    YUNOTANI, S
    HISATSUGU, T
    TAHARA, E
    INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (01) : 25 - 28
  • [30] Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability
    Fagundes, Rafaela
    Teixeira, Leonardo K.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9